Human drug approved for dog skin infections

FDA gives go-ahead to antibiotic for use in treating 'hot spots'

Slideshow

Image: To match FEATURE KAZAKHSTAN-EAGLES/

Animal Tracks
Find a hawk-eyed hunter, a snow-covered pup, a hungry chimp, a merry pair of ring-tailed lemurs — plus more images of cute critters.

more photos

Pet health videos

TODAY

TV show exposes ugly side of dog breeding
Dec. 10: A British documentary uncovers the dirty and dangerous elements behind what it takes to breed pedigree dogs, causing TV programmers to pull the plug on broadcasting a beloved dog show. TODAY’s Meredith Vieira reports.

From bow to wow: Pound pups' makeovers

Hidden dangers for overweight pets

Abandoned pups, kittens feel recession

Miracle pup survives 3 months in wilderness

updated 2:30 p.m. ET Sept. 8, 2004

WASHINGTON - The Food and Drug Administration approved using an antibiotic originally designed for humans to help treat skin infections suffered by dogs.

Simplicef was developed by Pharmacia & Upjohn Co., a division of Pfizer. Dogs ingest a single film-coated tablet once per day to treat wound infections caused by several types of bacteria including Escherichia coli, Pasteurella multocida and Staphylococcus aureus.

Infected dogs break out in rashes that redden, swell and roughen the dog’s skin. As infection worsens, “hot spots” can deepen, ooze and cause the dog’s hair to fall out.

Story continues below ↓

advertisement | your ad here

It is common for veterinarians to turn to antimicrobials approved for humans when dogs suffer similar skin infections. The FDA approval provides guidance on how much drug can safely be given to the canines once Simplicef is available to veterinarians this fall.